Data from NSCLC patients, in which both EGFR and ARID1A are frequently mutated, confirmed the relevance of this mutually exclusive genetic interaction between these two genes in the context of EGFR dependent tumors. This evidence concerns the gene EGFR and non-small cell lung carcinoma.